BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29784873)

  • 21. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
    Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
    Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
    Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
    BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers.
    Miyake M; Lawton A; Goodison S; Urquidi V; Gomes-Giacoia E; Zhang G; Ross S; Kim J; Rosser CJ
    BMC Cancer; 2013 Jul; 13():322. PubMed ID: 23815949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma.
    Kasashima H; Yashiro M; Nakamae H; Masuda G; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Nakane T; Hino M; Hirakawa K; Ohira M
    PLoS One; 2017; 12(6):e0178635. PubMed ID: 28575019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A-kinase interacting protein 1 might serve as a novel biomarker for worse prognosis through the interaction of chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) ligand 2 in acute myeloid leukemia.
    Hao X; Gu M; Sun J; Cong L
    J Clin Lab Anal; 2020 Feb; 34(2):e23052. PubMed ID: 31617252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A-kinase interacting protein 1, a potential biomarker associated with advanced tumor features and CXCL1/2 in prostate cancer.
    Wang D; Luo Y; Guo Y; Li G; Li F
    Int J Biol Markers; 2020 Jun; 35(2):74-81. PubMed ID: 32339056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Chemokine CXCL7 is Correlated with LDH-A and Predicts the Prognosis of Patients with Colorectal Cancer.
    Liang H; Li L; Huang B; Cheng G; Ao J; Hao S
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):166. PubMed ID: 38682188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
    Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
    Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low expression of B-Cell-Associated protein 31 is associated with unfavorable prognosis in human colorectal cancer.
    Ma C; Jin RM; Chen KJ; Hao T; Li BS; Zhao DH; Jiang H
    Pathol Res Pract; 2018 May; 214(5):661-666. PubMed ID: 29653744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MMP3 and CXCL1 are potent stromal protein markers of dysplasia-carcinoma transition in sporadic colorectal cancer.
    Sipos F; Germann TM; Wichmann B; Galamb O; Spisák S; Krenács T; Tulassay Z; Molnár B; Műzes G
    Eur J Cancer Prev; 2014 Sep; 23(5):336-43. PubMed ID: 24999605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma.
    Hu L; Wang RY; Cai J; Feng D; Yang GZ; Xu QG; Zhai YX; Zhang Y; Zhou WP; Cai QP
    Oncotarget; 2016 Oct; 7(41):66660-66678. PubMed ID: 27556502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.
    Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z
    Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance.
    Hu L; Chen HY; Han T; Yang GZ; Feng D; Qi CY; Gong H; Zhai YX; Cai QP; Gao CF
    Tumour Biol; 2016 Jan; 37(1):837-45. PubMed ID: 26254099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Vimentin Expression Predicts a Poor Prognosis and Progression in Colorectal Cancer: A Study with Meta-Analysis and TCGA Database.
    Du L; Li J; Lei L; He H; Chen E; Dong J; Yang J
    Biomed Res Int; 2018; 2018():6387810. PubMed ID: 29955607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
    Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
    Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of C-X-C motif chemokine ligands 1/2/8/13/14 with clinicopathological features and survival profile in patients with colorectal cancer.
    Luo X; Tai J; Zhao Y; Zhao P; Sun D; Wang L
    Oncol Lett; 2022 Oct; 24(4):348. PubMed ID: 36072008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of lncRNA AFAP1-AS1 correlates with poor prognosis and promotes tumorigenesis in colorectal cancer.
    Wang F; Ni H; Sun F; Li M; Chen L
    Biomed Pharmacother; 2016 Jul; 81():152-159. PubMed ID: 27261589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating Levels of VEGF and CXCL1 Are Predictive of Metastatic Organotropismin in Patients with Colorectal Cancer.
    Divella R; Daniele A; DE Luca R; Simone M; Naglieri E; Savino E; Abbate I; Gadaleta CD; Ranieri G
    Anticancer Res; 2017 Sep; 37(9):4867-4871. PubMed ID: 28870907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relationship between the expression of DDX39 protein and prognosis of colorectal cancer].
    Ma J; Chang W; Zhang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Mar; 21(3):336-341. PubMed ID: 29577224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.